Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection
- 28 August 2006
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 8 (12-13) , 2706-2714
- https://doi.org/10.1016/j.micinf.2006.07.018
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus InfectionJournal of Virology, 2005
- Avian Influenza — A Challenge to Global Health Care StructuresNew England Journal of Medicine, 2004
- Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvantJournal of Medical Virology, 2004
- Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virusJournal of Medical Virology, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNAScience, 2004
- Nasal Vaccination,Escherichia coliEnterotoxin, and Bell's PalsyNew England Journal of Medicine, 2004
- Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccineVaccine, 1999
- When Two Strands Are Better Than One: The Mediators and Modulators of the Cellular Responses to Double-Stranded RNAVirology, 1996
- IMMUNITY TO INFLUENZA IN MANAnnual Review of Microbiology, 1983